Latest in Cell & Gene Therapy

Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development

Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Industrial data mastery: navigating the 2025 landscape

As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
See more

Servier opens new €86m biologics production facility in Loiret, France

The company's Bio-S facility will be responsible for the production of biological medicines stemming from its R&D pipeline for preclinical and clinical studies

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

TrakCel to support cell and gene therapy orchestration with OCELLOS IT solution

The IT system allows cell and gene therapy (CGT) manufacturers to track the progress of personalised CGTs in real-time, while also managing their supply chain

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Cell & Gene Therapy

Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger

Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL

Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement

Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy

CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy

Sterling Pharma broadens its ADC development services with £10m investment into Deeside site

The CDMO's ADC development and manufacturing facility in Deeside has more than doubled in capacity, with a new Grade C cleanroom dedicated to ADC manufacturing

Picking a CDMO as a CGT developer: what to consider and why

Cell and gene therapy development and manufacture can be risky and highly complex, so biopharma companies would benefit from investing in a reliable and experienced CDMO

Merck bolsters its ADC CDMO offering with €71m Missouri manufacturing site expansion

The facility's expansion has tripled its ADC manufacturing capacity, bolstering Merck's CDMO offering for current and new clients

Lonza extends its ADC manufacturing collaboration with biopharma giant through bioconjugation services

The CDMO will be responsible for the bioconjugation of the client's new solid tumour-targeting ADC, which will occur at its Visp site once it's extended

Donaldson's Isolere Bio launches IsoTag reagent for optimal AAV purification

The IsoTag AAV reagent can purify adeno associated viruses for research purposes, achieving up to an 85% in yield

Why potency assays are a crucial consideration for CGT manufacturers

Potency assays can enhance the efficiency of cell and gene therapy development and commercialisation while also bringing down costs

Fresenius Kabi and Cellular Origins partner to scale CGT manufacturing

Cellular Origins will provide its automated cell and gene therapy platform, Constellation, to the CMO, so customers can access 24/7 CGT manufacturing services

Achieving sustainable oligonucleotide production at an industrial scale

Sustainability is becoming increasingly important in pharmaceutical manufacturing, so Bachem's Philipp Markolin shares some insight into planet-friendly peptide and oligonucleotide manufacturing

Sponsor content

Merck launches single-use reactor designed to accelerate antibody drug conjugate manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing. It increases efficiency by 70% compared to stainless steel or glass manufacturing methods and...

Cell culture bags - Understanding the basics

Uncover the benefits of cell culture bags and why they could be the ideal solution for your cell processing application.

Symbiosis Pharmaceutical Services shares the industry events it will attend in 2024

The aseptic manufacturing specialists will have an exhibiting presence at an additional 5 events globally this year

CordenPharma launches lipid nanoparticle starter kits

The kits will aid in loss mitigation of high-value payloads during the gene editing journey to market

COVID-19: a tale of two conditions

The virus coronavirus SARS CoV-2 (severe acute respiratory syndrome coronavirus 2), which causes COVID-19, may have been named prematurely, reports Steve Walton, who works...

RNA therapeutics to become a dominant treatment within a decade

New white paper from the Chinese pharma WuXi AppTec features industry experts pointing to the beginnings of a new era for RNA therapeutics

DNA sequencer uses naturally occurring light for ultra precise positioning

Light generated by the natural process of DNA replication provides the user with exceptionally high resolution and low pass noise filtering when using the encoder

Metrion Biosciences and Peakdale Molecular sign integrated drug discovery partnership

Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has...

Lion Biotechnologies announces new manufacturing services agreement with WuXi AppTec

Scientists Successfully Create Blood from Skin Cells

Researchers in Singapore have artificially generated new mouse blood and immune cells from skin cells.